DE60033566D1 - Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen - Google Patents

Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen

Info

Publication number
DE60033566D1
DE60033566D1 DE60033566T DE60033566T DE60033566D1 DE 60033566 D1 DE60033566 D1 DE 60033566D1 DE 60033566 T DE60033566 T DE 60033566T DE 60033566 T DE60033566 T DE 60033566T DE 60033566 D1 DE60033566 D1 DE 60033566D1
Authority
DE
Germany
Prior art keywords
sertraline hydrochloride
polymorphes
new
production
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60033566T
Other languages
English (en)
Other versions
DE60033566T2 (de
Inventor
Judith Aronhime
Marioana Mendelovici
Tamar Nidam
Claude Singer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Application granted granted Critical
Publication of DE60033566D1 publication Critical patent/DE60033566D1/de
Publication of DE60033566T2 publication Critical patent/DE60033566T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
DE60033566T 1999-12-21 2000-12-21 Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen Expired - Fee Related DE60033566T2 (de)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US17134199P 1999-12-21 1999-12-21
US171341P 1999-12-21
US18733600P 2000-03-06 2000-03-06
US187336P 2000-03-06
US18791000P 2000-03-08 2000-03-08
US187910P 2000-03-08
US19060300P 2000-03-20 2000-03-20
US190603P 2000-03-20
PCT/US2000/035178 WO2001045692A1 (en) 1999-12-21 2000-12-21 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

Publications (2)

Publication Number Publication Date
DE60033566D1 true DE60033566D1 (de) 2007-04-05
DE60033566T2 DE60033566T2 (de) 2007-10-25

Family

ID=27496950

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60033566T Expired - Fee Related DE60033566T2 (de) 1999-12-21 2000-12-21 Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen

Country Status (19)

Country Link
US (2) US6452054B2 (de)
EP (2) EP1797875A3 (de)
JP (2) JP4057295B2 (de)
KR (1) KR100791872B1 (de)
CN (1) CN1434708A (de)
AT (1) ATE354358T1 (de)
AU (1) AU780771B2 (de)
DE (1) DE60033566T2 (de)
DK (1) DK1248605T3 (de)
ES (1) ES2281374T3 (de)
HR (1) HRP20020543A2 (de)
HU (1) HUP0204010A3 (de)
IL (1) IL150332A0 (de)
IS (1) IS6425A (de)
PL (1) PL356452A1 (de)
PT (1) PT1248605E (de)
SK (1) SK8872002A3 (de)
WO (1) WO2001045692A1 (de)
YU (1) YU47902A (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5845313A (en) 1995-07-31 1998-12-01 Lexar Direct logical block addressing flash memory mass storage architecture
US6978342B1 (en) 1995-07-31 2005-12-20 Lexar Media, Inc. Moving sectors within a block of information in a flash memory mass storage architecture
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) * 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
ATE354358T1 (de) 1999-12-21 2007-03-15 Teva Pharma Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen
US6552227B2 (en) * 2000-03-14 2003-04-22 Teva Pharmaceutical Industries Ltd. Process for preparing (+)-cis-sertraline
EP1397342A1 (de) * 2001-05-31 2004-03-17 Orion Corporation Fermion Verfahren zur herstellung von sertralinzwischenprodukten
CA2448279A1 (en) 2001-05-31 2002-12-05 Orion Corporation Fermion Process for preparing sertraline hydrochloride polymorphic form ii
GB0123421D0 (en) 2001-09-28 2001-11-21 Memquest Ltd Power management system
WO2003093217A1 (en) * 2002-04-29 2003-11-13 Teva Pharmaceutical Industries Ltd. Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
WO2005000786A1 (en) * 2003-05-23 2005-01-06 Transform Pharmaceuticals, Inc. Sertraline compositions
CA2537804A1 (en) * 2003-09-05 2005-03-17 Teva Pharmaceutical Industries Ltd A recycling process for preparing sertraline
RU2376279C2 (ru) * 2003-11-04 2009-12-20 Сипла Лимитед Способ получения полиморфов ингибитора повторного захвата серотонина (варианты)
US7464306B1 (en) 2004-08-27 2008-12-09 Lexar Media, Inc. Status of overall health of nonvolatile memory
US7345201B2 (en) * 2005-02-23 2008-03-18 Teva Pharmaceutical Industries, Ltd. Processes for preparing sertraline
WO2006103506A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Sertraline-containing pharmaceutical compositions and a process for preparation thereof
GB0507090D0 (en) * 2005-04-07 2005-05-11 Sandoz Ag Process for preparing polymorphic form ll of sertraline hydrochloride
US7518019B2 (en) * 2006-06-01 2009-04-14 Hetero Drugs Limited Processes for preparing sertraline hydrochloride crystalline forms
US20060257475A1 (en) * 2006-08-17 2006-11-16 Boehringer Ingelheim International Gmbh Stable Sertraline Hydrochloride Formulation and Method
CA2594198A1 (en) * 2007-07-20 2009-01-20 Apotex Pharmachem Inc. A novel process for the preparation of sertraline hydrochloride form ii
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
CN114890943A (zh) 2013-11-15 2022-08-12 阿克比治疗有限公司 {[5-(3-氯苯基)-3-羟基吡啶-2-羰基]氨基}乙酸固体形式，组合物和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114947D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) * 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
HUP0101322A3 (en) 1998-03-18 2002-06-28 Ciba Sc Holding Ag Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines
JP2000026379A (ja) * 1998-07-08 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンメタノール和物および塩酸セルトラリンエタノール和物、ならびにそれらの製法
IL143311A0 (en) * 1998-11-27 2002-04-21 Teva Pharma Sertraline hydrochloride polymorphs
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
ATE354358T1 (de) * 1999-12-21 2007-03-15 Teva Pharma Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen
IN192343B (de) 2000-05-26 2004-04-10 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
US6858652B2 (en) 2005-02-22
SK8872002A3 (en) 2002-12-03
EP1248605B1 (de) 2007-02-21
JP2007308505A (ja) 2007-11-29
WO2001045692A9 (en) 2002-07-04
HUP0204010A3 (en) 2006-02-28
US6452054B2 (en) 2002-09-17
PT1248605E (pt) 2007-03-30
EP1797875A3 (de) 2007-08-29
DE60033566T2 (de) 2007-10-25
HRP20020543A2 (en) 2005-04-30
US20010041815A1 (en) 2001-11-15
JP2003518056A (ja) 2003-06-03
ES2281374T3 (es) 2007-10-01
HUP0204010A2 (hu) 2003-04-28
ATE354358T1 (de) 2007-03-15
EP1248605A2 (de) 2002-10-16
IS6425A (is) 2002-06-18
KR20020062356A (ko) 2002-07-25
EP1248605A4 (de) 2004-11-24
IL150332A0 (en) 2002-12-01
JP4057295B2 (ja) 2008-03-05
DK1248605T3 (da) 2007-03-19
WO2001045692A1 (en) 2001-06-28
AU2737601A (en) 2001-07-03
US20030023117A1 (en) 2003-01-30
CN1434708A (zh) 2003-08-06
AU780771B2 (en) 2005-04-14
PL356452A1 (en) 2004-06-28
YU47902A (sh) 2005-11-28
EP1797875A2 (de) 2007-06-20
KR100791872B1 (ko) 2008-01-07

Similar Documents

Publication Publication Date Title
DE60033566D1 (de) Neue sertralinhydrochlorid polymorphe, verfahren zur herstellung und zur verwendung und diese enthaltende zusammensetzungen
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
UY26813A1 (es) Compuestos para tratar enfermedad de alzheimer
ATE458754T1 (de) Screening-verfahren, verfahren zur aufreinigung nichtdiffundierbarer a-beta-oligomere, selektive antikörper gegen diese nichtdiffundierbaren a- beta-oligomere und verfahren zur herstellung dieser antikörper
ATE493433T1 (de) Neue zusammensetzung und verfahren zur behandlung von immunerkrankungen
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
DE60229267D1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
BRPI0411294A (pt) derivados de amino-propanol
DE602004019897D1 (de) Verfahren zur racematspaltung von 2,4-diamino-3,6-dihydro-1,3,5-triazinen, die sich zur behandlung vkrankungen eignen
BRPI0418120A (pt) composto, composição farmacêutica, e, métodos para tratar um distúrbio, uma doença ou distúrbio, e para tratar mieloma múltiplo ou leucemia
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
DE59010690D1 (de) Vefahren zur Herstellung von Ozon
DE60228724D1 (de) Verfahren zur herstellung von beraprost und dessen salzen
DE3767993D1 (de) Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine.
ATE277915T1 (de) Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
DE60012587D1 (de) Friedel-craft verfahren zur herstellung von thioxanthonen
ATE334680T1 (de) 4-aminopiperidin-derivate, verfahren zur herstellung und ihre verwendung als arzneimittel
ATE421961T1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält
DE60211303D1 (de) Verfahren zur herstellung und zwischenprodukte von pyridin-2-yl-amin
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
DE69619868D1 (de) Piperazinylalkylthiopyrimidin derivate, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung
DE60107292D1 (de) Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE60112241D1 (de) Verfahren und zwischenverbindungen zur herstellung von imidazopyridinen
BR0205220A (pt) Derivados de fenilpiperazina, método para a preparação de um composto, composição farmacêutica, e, métodos de tratamento do mal de parkinson, e de distúrbios de cns tais como esquizofrenia, ansiedade e depressão

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee